Mounjaro vs Zepbound is a 2026 U.S. search because both Eli Lilly pens contain tirzepatide. They are not the same prescription. Mounjaro is FDA-approved for type 2 diabetes. Zepbound is FDA-approved for chronic weight management in eligible adults and for obstructive sleep apnea in adults with obesity when prescribed for that use. A pharmacy cannot swap the boxes to chase a lower copay.
What is the same, and what is not
- Ingredient: tirzepatide in both
- Schedule: once weekly injection, with a titration your prescriber sets
- Label and pen: different brands, different approved uses, different insurance rules
- Cash price: both are often near $1,000 a month without coverage. See Mounjaro price per month and Zepbound cost without insurance
Why U.S. insurance treats them differently
Many commercial plans and Medicare Part D formularies cover diabetes medicines more readily than weight-management medicines. A denial for Zepbound does not mean Mounjaro will pay, and the reverse is also true. The plan looks at the drug name, the diagnosis, and prior authorization. Ask your prescriber which brand matches your chart before you compare coupons.
If you are also looking at semaglutide, read semaglutide vs tirzepatide. That is a different ingredient choice, not a brand swap inside tirzepatide.
How to order the one that was written
Match the pharmacy quote to the brand, strength, and quantity on the prescription. Upload it at rx upload. Pens need cold-chain shipping. Do not buy tirzepatide from a site that skips the prescription.
Medical Disclaimer
This article is informational only and is not medical, insurance, or legal advice. Do not start, stop, or change a prescription without your clinician. Prices, Medicare rules, and manufacturer programs change. Affordable Rx Meds does not guarantee any price or coverage outcome. A valid prescription is required to order.